Your browser doesn't support javascript.
loading
[How we treat acute myeloid leukemia in the era of new drugs].
Yang, X F; Chen, S N; Wu, D P.
Affiliation
  • Yang XF; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Chen SN; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Wu DP; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Zhonghua Nei Ke Za Zhi ; 61(9): 1066-1068, 2022 Sep 01.
Article in Zh | MEDLINE | ID: mdl-36008304
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Nei Ke Za Zhi Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Nei Ke Za Zhi Year: 2022 Document type: Article Affiliation country: